NYU Langone Health to adopt new Philips health technology solutions in multi-year partnership directed at patient safety, quality and outcomes
November 16 2023 - 9:37AM
November 16, 2023
To unlock patient data for precision diagnosis and treatment,
the new partnership includes digital pathology, clinical
informatics, and innovative AI-enabled diagnostics with an
enterprise monitoring as a service model
New York, NY – Royal Philips (NYSE: PHG,
AEX: PHIA) a global leader in health technology, and NYU Langone
Health, the nation’s top-ranked academic medical center, [1] today
announced an 8-year strategic partnership valued up to USD 115
million and aimed at enhancing patient care through further
innovation. With the new technologies, NYU Langone clinicians can
collaborate in real-time, whether sharing pathology, imaging
studies or patient data to support diagnostic confidence and tailor
individualized care plans. This integrated, collaborative approach
will serve as part of a drive to further enhance the patient
experience through faster diagnosis and treatment, and improved
outcomes.
Supported by Philips’ innovation and leadership in health
technology, NYU Langone’s industry-leading knowledge of the patient
journey and care pathways can help push the boundaries of
personalized care. “As one of the most digitally advanced health
systems in the nation, NYU Langone Health empowers our clinicians
to easily transform data into insights that can help us further
elevate the world-class care and exceptional outcomes we provide to
our patients,” said Nader Mherabi, Chief Digital and Information
Officer at NYU Langone. “Further harnessing big data is the next
step in our commitment to ensuring that NYU Langone remains at the
forefront of innovation and precision medicine that our patients
have to come to expect.”
“NYU Langone has always been a trailblazer when it comes to
technology adoption and providing world-class patient care. With
the adoption of these technologies, they are forefront of
leveraging a new enterprise monitoring platform and business model
to help enable a better patient experience, improved staff
productivity and reduced cost of care,” said Julia Strandberg,
Chief Business Leader, Connected Care for Philips. “At the same
time, they understand the real value of technology allowing
clinicians to focus on what matters most – providing the best care
possible to their patients.”
As part of its focus on data access through consolidated
technology systems, NYU Langone is committed to unifying patient
monitoring systems, simplifying workflows, and creating
standards-based interoperability with its electronic medical record
(EMR).
With this new partnership, NYU Langone Health will be adopting
Philips’ IntelliSite Pathology solution, enterprise informatics,
and AI-enabled diagnostic imaging technologies such as the Philips
Lumify Handheld Ultrasound. NYU Langone will also utilize the
Philips Patient Information Center iX and the Philips Capsule
Medical Device Information Platform (MDIP) to simplify workflows
and unlock the power of data.
MDIP is designed to bring together disparate data from medical
devices and systems into a single unified view. When deployed with
Philips PIC iX in a predictable Enterprise Monitoring as a Services
(EMaaS) subscription model, the combined solutions are intended to
provide seamless integration across the network.
Led by NYU Langone’s Chief Scientific Officer, Executive Vice
President and Vice Dean for Science Dr. Dafna Bar-Sagi alongside
Philips Chief Innovation & Strategy Officer Shez Partovi, the
two organizations have also deepened their existing partnership
through the development of new research programs initially focused
on a roadmap for the future of digital pathology, patient
monitoring, ultrasound, and MRI.
“Our access to transformative health care technologies developed
by Philips will provide our researchers with countless
opportunities to advance knowledge and develop new diagnostic and
treatment modalities that enhance patient care, safety and
outcomes,” said Bar-Sagi.
[1] As an institution, NYU Langone consistently receives
top-quality and safety accolades from independent arbiters of
patient care. NYU Langone is recognized by Vizient, Inc., as the
No. 1 comprehensive academic medical center and the No. 1
ambulatory system for quality and safety in the United
States. The health system has 10 clinical specialties ranked
in the top 10 nationally by U.S. News & World Report,
including the No. 1 ranking for neurology and neurosurgery. NYU
Langone also consistently receives “A” ratings on the Leapfrog
Hospital Safety Grade and five-star ratings for safety, quality,
and patient experience from the Centers for Medicare and Medicaid
Services (CMS).
For further information, please contact:
Meredith AmorosoPhilips Global Press OfficeTel: +1
724-584-8991E-mail: meredith.amoroso@philips.com
Silvie CasanovaPhilips North AmericaTel: +1 781 879 0692Email:
silvie.casanova@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring
and enterprise informatics, as well as in personal health. Philips
generated 2022 sales of EUR 17.8 billion and employs approximately
70,700 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
- Leaders from NYU Langone Health and Philips come together
- NYU Langone Health
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From May 2023 to May 2024